Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.126.049422 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Andrew M Freddo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus OH USA. Hauptthemen laut MEDLINE: Fontan Procedure, Practice Patterns, Physicians', Heart Defects, Congenital, Cardiovascular Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Background
There are limited data on prescription patterns in adolescents and adults with Fontan circulation.
Methods
We conducted a retrospective analysis of patients 13 years of age and older enrolled between 2022 and 2024 in the Fontan Outcomes Network (now SV‐ONE [Single Ventricle Outcomes Network]) who had undergone Fontan operation without subsequent Fontan takedown or heart transplantation. Demographics, clinical variables, and medications prescribed were assessed. Logistic regression was used to identify factors associated with prescribed cardiac medications.
Results
There were 639 patients (age range 13–67 years, 55.6% male, 81.1% White race, 46.8% dominant left ventricle) enrolled at 16 centers. The most frequently prescribed medication classes were antiplatelets (75.6%) and renin‐angiotensin system inhibitors (55.9%). Direct oral anticoagulant prescription (15.0%) exceeded that of warfarin (11.6%). SGLT2 (sodium glucose cotransporter 2) inhibitors were prescribed to 6.3% of patients, and angiotensin receptor/neprilysin inhibitors were prescribed to 2.2%. Moderate or severely decreased systolic ventricular function was most strongly associated with prescription of digoxin (odds ratio [OR], 4.2 [95% CI, 2.1–8.3]). Protein losing enteropathy was most strongly associated with prescription of diuretics (OR, 22.9 [95% CI, 8.1–64.9]), mineralocorticoid receptor agonists (OR, 5.3 [95% CI, 2.4–11.8]), and pulmonary vasodilators (OR, 5.2 [95% CI, 2.5–10.8]).
Conclusions
In a multicenter cohort of adolescents and adults with Fontan circulation, medications indicated for biventricular heart failure with reduced ejection fraction are often used despite an absence of supportive evidence in this distinct circulation. Future prospective analysis may provide further insight into shifting prescribing patterns and response to therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus OH USA.
- Division of Cardiology, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia PA USA.
- Division of Cardiovascular Medicine, Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA USA.
- Department of Pediatrics Duke University Medical Center Durham NC USA.
- Division of Cardiology Phoenix Children's Hospital, University of Arizona Phoenix Phoenix AZ USA.
- Division of Pediatric Cardiology, Department of Pediatrics University of Utah Salt Lake City UT USA.
ORCID-Profile: Andrew M Freddo, Humera Ahmed, Jonathan B Edelson, Sara Partington, Allison L Tsao, Juan M Ortega-Legaspi, Yuli Y Kim, Adeola O Awujoola, Deepti P Bhat, Reid C Chamberlain, Sharon Chen, Stephen J Dolgner, Andrew S Mackie, Alexander R Opotowsky, Sumeet Vaikunth
Förderung
- NCATS NIH HHS
Zitieren
APA
Freddo, A. M., Ahmed, H., Edelson, J. B., Partington, S., Ruckdeschel, E., Tsao, A. L., Ortega-Legaspi, J. M., Kim, Y. Y., Awujoola, A. O., Bhat, D. P., Chamberlain, R. C., Chen, S., Dolgner, S. J., Mackie, A. S., Opotowsky, A. R., Vaikunth, S., & SV‐ONE Investigators (2026). Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.049422
Vancouver
Freddo AM, Ahmed H, Edelson JB, Partington S, Ruckdeschel E, Tsao AL, et al. Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.049422
BibTeX
@article{Freddo2026,
author = {Freddo, Andrew M and Ahmed, Humera and Edelson, Jonathan B and Partington, Sara and Ruckdeschel, Emily and Tsao, Allison L and Ortega-Legaspi, Juan M and Kim, Yuli Y and Awujoola, Adeola O and Bhat, Deepti P and Chamberlain, Reid C and Chen, Sharon and Dolgner, Stephen J and Mackie, Andrew S and Opotowsky, Alexander R and Vaikunth, Sumeet and SV‐ONE Investigators, SV‐ONE Investigators},
title = {Prescription Patterns of Cardiovascular Medications in the Adolescent and Adult Population With Fontan Circulation—A Report From the Multicenter Single Ventricle Outcomes Network},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.049422}
}
EUVIMED